BIANCHI, LUCIANO
 Distribuzione geografica
Continente #
NA - Nord America 422
EU - Europa 322
AS - Asia 89
SA - Sud America 19
AF - Africa 12
Totale 864
Nazione #
US - Stati Uniti d'America 420
DE - Germania 87
FI - Finlandia 49
IT - Italia 40
IE - Irlanda 34
SE - Svezia 34
RU - Federazione Russa 33
SG - Singapore 31
HK - Hong Kong 28
CN - Cina 21
BR - Brasile 17
UA - Ucraina 13
GB - Regno Unito 12
CI - Costa d'Avorio 8
FR - Francia 5
IN - India 5
BE - Belgio 3
ES - Italia 3
MA - Marocco 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
AT - Austria 1
CA - Canada 1
CL - Cile 1
CO - Colombia 1
EG - Egitto 1
KR - Corea 1
MX - Messico 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
SY - Repubblica araba siriana 1
TR - Turchia 1
VN - Vietnam 1
Totale 864
Città #
Munich 82
Chandler 80
Ashburn 43
Helsinki 43
Des Moines 39
Dublin 34
Hong Kong 28
Boardman 25
Fairfield 20
Singapore 16
Jacksonville 14
New York 13
The Dalles 13
Turin 13
Wilmington 12
Lawrence 10
Princeton 10
Abidjan 8
San Diego 8
San Mateo 8
Seattle 8
Washington 8
Woodbridge 7
Moscow 6
Ann Arbor 5
London 5
Los Angeles 5
Milan 5
Pune 5
Ascoli Piceno 4
Centro 4
Jyväskylä 4
Cambridge 3
Guangzhou 3
Houston 3
Shenzhen 3
Brussels 2
Chicago 2
Chiswick 2
Dallas 2
Fayetteville 2
Matera 2
Redmond 2
Rome 2
Shanghai 2
Stockholm 2
Verona 2
Wuhan 2
Aracruz 1
Barra Mansa 1
Beijing 1
Belém 1
Boydton 1
Bucaramanga 1
Cairo 1
Cajamar 1
Campinas 1
Centro Municipality 1
Contagem 1
Duartina 1
Farroupilha 1
Frankfurt am Main 1
Grandes Rios 1
Guararema 1
Hanoi 1
Hasselt 1
Izmir 1
Jiaxing 1
Joinville 1
Juiz de Fora 1
Kharkiv 1
Kilburn 1
Manchester 1
Olomouc 1
Oslo 1
Ottawa 1
Piracicaba 1
Santa Clara 1
Santiago 1
Suffern 1
São José dos Quatro Marcos 1
São João da Boa Vista 1
São Paulo 1
Taiyuan 1
Tatuí 1
Ternopil 1
Tolentino 1
Warsaw 1
Weitang 1
Yiwu 1
Totale 663
Nome #
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study 174
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 89
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore 86
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis 81
Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face 68
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 63
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort study 51
Prevalence of HPV genital infection in patients with moderate-to-severe psoriasis undergoing systemic treatment with immunosuppressive agents or biologics 49
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 48
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 40
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019 39
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic 32
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 31
null 28
Totale 879
Categoria #
all - tutte 5.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.928


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 0 7
2020/202170 2 9 3 1 8 2 1 6 2 8 19 9
2021/202256 0 6 0 0 2 5 0 4 5 3 13 18
2022/2023252 14 26 12 15 18 67 0 17 56 3 21 3
2023/2024146 23 7 10 14 25 41 2 4 2 7 2 9
2024/2025327 20 20 4 4 11 48 68 36 72 16 28 0
Totale 879